• About
  • Subscribe
  • Advertise
  • Contact
Saturday, March 14, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Medical bodies urge caution in new guidance on use of AI scribes

by Staff Writer
September 2, 2024
in Ahpra/National Boards, Local, News
Reading Time: 4 mins read
A A
Medical bodies are acknowledging the potential of AI but urging caution for health professionals. Image: ipopba/stock.adobe.com

Medical bodies are acknowledging the potential of AI but urging caution for health professionals. Image: ipopba/stock.adobe.com

Share on FacebookShare on Twitter

Artificial Intelligence (AI) scribes can help reduce the administrative burden but they can’t replace the work of a health professional and must be used with caution, says Australia’s peak body for general practitioners.

The Royal Australian College of GPs (RACGP) and the Australian Health Practitioner Regulation Agency (Ahpra) have released new guidance on using AI scribes.

Key points from the guidance include:

  • Ahpra supports the safe use of AI in healthcare, recognising its potential to improve health outcomes and create a more person-centred health system.
  • RACGP acknowledges that AI has great potential in general practice, while emphasising the need for careful risk mitigation.
  • Both organisations stress that practitioners remain responsible for delivering safe, quality care when using AI tools.
  • Transparency with patients and obtaining informed consent are highlighted as important considerations.

RACGP President Dr Nicole Higgins said AI scribes can help GPs and their patients.

“The administrative burden on GPs needs to be reduced urgently,” she said.

“Our annual Health of the Nation report found GPs are increasingly reporting the administrative workload and associated stress among their greatest concerns.

“Where AI scribes can help is in automating parts of clinical note-taking. For example, they can convert conversations into notes, which can be incorporated into health records, and given to patients to help them remember and follow the advice.

“These tools will also allow GPs to focus on the patient instead of their computer during a consult, meaning happier patients,” Dr Higgins said.

“However, AI scribes need to be used with caution as it is an emerging technology and there are risks.

“Patients must be informed and provide consent for them to be used during a consultation. And GPs need to ensure the tool they use is compliant with Australian laws for safe data collection and storage.

“It’s important to understand AI scribes cannot replace the work GPs do to prepare clinical documentation, and doctors must carefully check their output for accuracy, as they can make mistakes.”

“Everyone deserves the quality care that comes from having a GP who knows you, and your health history – AI can never replace this relationship. But it can help with administrative tasks, and this will help GPs focus more on our patients, which is what we want.”

Despite that sense of caution, at least one clinician has hailed the guidance as a “game-changer”.

Mr Darren Ross, chief executive of PatientNotes and a musculoskeletal physiotherapist with over 25 years of clinical experience, said the guidance provided “much-needed clarity”.

“This clarity from Ahpra and the RACGP is a game-changer for the healthcare industry. It provides a solid framework for practitioners to confidently embrace AI tools that can significantly enhance patient care and reduce administrative burdens,” he said.

“It means that when they encounter AI-powered tools like PatientNotes in their healthcare journey, they can be confident that these technologies are being used responsibly, with their privacy protected and their best interests in mind.”

More reading

Insight August 2024: Spotlight on Presbyopia and Artificial Intelligence

Bringing telehealth and artificial intelligence into real-world ophthalmology practice

Artificial intelligence: eyecare’s friend of foe?Contact Lens Company set for ASX listing

Related Posts

Virtual reality offers some possible risks but also a number of opportunities, particularly in eyecare. Image: Olly/stock.adobe.com.

Virtually real, visually relevant: What VR means for paediatric optometry

by Hayley McDonald
March 13, 2026

At the completion of this article, the reader should… •  Recognise common concerns and current evidence regarding the visual risks...

The Humphrey Field Analyzer has evolved over more than 40 years. Image: ZEISS.

ZEISS celebrating over 40 years of Humphrey Field Analyzer

by Rob Mitchell
March 13, 2026

ZEISS is celebrating over 40 years of the Humphrey Field Analyzer with promotional discounts on selected HFA 3 models for...

David Beckham's new range includes sunglasses and optical frames across two product lines. Image: Safilo

Safilo launches David Beckham spring/summer range

by Staff Writer
March 13, 2026

Safilo Group has announced the release of the spring/summer 2026 collection from Eyewear by David Beckham. The company says the...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited